Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $6,770 - $7,914
-211 Reduced 3.31%
6,164 $204,000
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $14,447 - $16,716
-400 Reduced 5.9%
6,375 $233,000
Q4 2022

Jan 18, 2023

SELL
$41.75 - $54.5 $22,169 - $28,939
-531 Reduced 7.27%
6,775 $0
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $21,693 - $32,156
-525 Reduced 6.7%
7,306 $431,000
Q3 2021

Oct 18, 2021

BUY
$39.25 - $50.42 $8,831 - $11,344
225 Added 2.96%
7,831 $337,000
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $4,488 - $5,085
-125 Reduced 1.62%
7,606 $298,000
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $258,911 - $291,999
7,731 New
7,731 $280,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Crew Capital Management, Ltd. Portfolio

Follow Crew Capital Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crew Capital Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Crew Capital Management, Ltd. with notifications on news.